• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Large-scale screening for somatic mutations in lung cancer.

作者信息

Rosell Rafael, Karachaliou Niki

机构信息

Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona 08916, Spain.

Autonomous University of Barcelona, Germans Trias i Pujol Health Sciences Research Institute and Hospital, Badalona, Spain.

出版信息

Lancet. 2016 Apr 2;387(10026):1354-1356. doi: 10.1016/S0140-6736(15)01125-3. Epub 2016 Jan 15.

DOI:10.1016/S0140-6736(15)01125-3
PMID:26777918
Abstract
摘要

相似文献

1
Large-scale screening for somatic mutations in lung cancer.肺癌体细胞突变的大规模筛查。
Lancet. 2016 Apr 2;387(10026):1354-1356. doi: 10.1016/S0140-6736(15)01125-3. Epub 2016 Jan 15.
2
Transcriptional profiling of non-small cell lung cancer using oligonucleotide microarrays.
Chest. 2002 Mar;121(3 Suppl):44S. doi: 10.1378/chest.121.3_suppl.44s.
3
Five-gene signature in non-small-cell lung cancer.
N Engl J Med. 2007 Apr 12;356(15):1582; author reply 1583.
4
Five-gene signature in non-small-cell lung cancer.
N Engl J Med. 2007 Apr 12;356(15):1582-3; author reply 1583.
5
Five-gene signature in non-small-cell lung cancer.
N Engl J Med. 2007 Apr 12;356(15):1582; author reply 1583.
6
Differences of gene expression in non-small cell lung cancer: are histology, tumor site, and methodology relevant?非小细胞肺癌中基因表达的差异：组织学、肿瘤部位和方法学是否相关？
J Thorac Oncol. 2010 Aug;5(8):1310-1; author reply 1311. doi: 10.1097/JTO.0b013e3181e7c165.
7
Refining prognosis in non-small-cell lung cancer.非小细胞肺癌预后的优化
N Engl J Med. 2007 Jan 11;356(2):189-90; author reply 190-1. doi: 10.1056/NEJMc062409.
8
[Molecular profiling of non-small cell lung cancer].
Rev Pneumol Clin. 2014 Feb-Apr;70(1-2):47-62. doi: 10.1016/j.pneumo.2013.11.005. Epub 2014 Feb 22.
9
MicroRNA in lung cancer.肺癌中的微小RNA
J Thorac Oncol. 2006 Nov;1(9):929-31.
10
Imaging and genomics: is there a synergy?影像学与基因组学：二者存在协同作用吗？
Radiology. 2012 Aug;264(2):329-31. doi: 10.1148/radiol.12120871.

引用本文的文献

1
Assessing Diversity Scaling in Lung Cancer Microbiome Across Individuals and Tissue Types.评估肺癌微生物组在个体和组织类型间的多样性缩放情况。
Microbiologyopen. 2025 Aug;14(4):e70036. doi: 10.1002/mbo3.70036.
2
Combining recombinant human endostatin with third-generation EGFR-TKIs in advanced EGFR-sensitive mutant non-small cell lung cancer.重组人内皮抑素与第三代表皮生长因子受体酪氨酸激酶抑制剂联合用于晚期表皮生长因子受体敏感突变型非小细胞肺癌
J Thorac Dis. 2025 Jul 31;17(7):5223-5237. doi: 10.21037/jtd-2025-1223. Epub 2025 Jul 25.
3
EGFR-mutant lung adenocarcinoma transformed into small cell Lung cancer: A case report and literatures review.
表皮生长因子受体（EGFR）突变型肺腺癌转化为小细胞肺癌：一例报告及文献综述
Respir Med Case Rep. 2025 Apr 18;55:102219. doi: 10.1016/j.rmcr.2025.102219. eCollection 2025.
4
[Research Progress on Imaging Diagnosis of Non-small Cell Lung Cancer 
Which Invades Pleura or Chest Wall].[侵犯胸膜或胸壁的非小细胞肺癌的影像学诊断研究进展]
Zhongguo Fei Ai Za Zhi. 2025 Feb 20;28(2):131-137. doi: 10.3779/j.issn.1009-3419.2025.106.04.
5
Analysis of gene expression of Babesia gibsoni cultured with diminazene aceturate using RNA sequencing.使用RNA测序分析用乙酰马啉培养的吉氏巴贝斯虫的基因表达。
J Vet Med Sci. 2025 Feb 4;87(2):181-188. doi: 10.1292/jvms.24-0395. Epub 2024 Dec 30.
6
Opening avenue for the targeted treatment of lung cancer using xanthohumol loaded nanostructured lipid carriers.利用负载黄腐酚的纳米结构脂质载体为肺癌靶向治疗开辟途径。
EXCLI J. 2024 Aug 28;23:1068-1070. doi: 10.17179/excli2024-7656. eCollection 2024.
7
Clinical Utility of Circulating Tumor DNA for Detecting Lung Cancer Mutations by Targeted Next-Generation Sequencing With Insufficient Tumor Samples.循环肿瘤 DNA 通过靶向下一代测序检测肺癌突变的临床实用性：肿瘤样本不足时。
J Clin Lab Anal. 2024 Oct;38(19-20):e25099. doi: 10.1002/jcla.25099. Epub 2024 Sep 24.
8
Two nomograms constructed for predicting the efficacy and prognosis of advanced non‑small cell lung cancer patients treated with anti‑PD‑1 inhibitors based on the absolute counts of lymphocyte subsets.基于淋巴细胞亚群绝对计数构建的预测抗 PD-1 抑制剂治疗晚期非小细胞肺癌患者疗效和预后的两个列线图。
Cancer Immunol Immunother. 2024 Jun 4;73(8):152. doi: 10.1007/s00262-024-03738-x.
9
Efficacy and safety of immune checkpoint inhibitors plus recombinant human endostatin therapy as second-line treatment in advanced non-small-cell lung cancer with negative driver gene: a pilot study.免疫检查点抑制剂联合重组人内皮抑素治疗驱动基因阴性的晚期非小细胞肺癌二线治疗的疗效和安全性：一项前瞻性研究。
Front Oncol. 2023 Nov 7;13:1210267. doi: 10.3389/fonc.2023.1210267. eCollection 2023.
10
Perceptions and feelings of a French sample regarding lung cancer screening.法国人群对肺癌筛查的认知和感受。
BMC Public Health. 2023 Nov 24;23(1):2333. doi: 10.1186/s12889-023-17110-8.